This is a demo store. No orders will be fulfilled.

Socazolimab (anti-PD-L1) - Primary antibody, specific to CD274, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Programmed cell death 1 ligand 1 inhibitor, INHIBITOR of Programmed cell death 1 ligand 1 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab182948
Grouped product items
SKU Size
Availability
Price Qty
Ab182948-100μg
100μg
10
$69.90
Ab182948-1mg
1mg
4
$349.90
Ab182948-5mg
5mg
1
$909.90
Ab182948-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,459.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Socazolimab (anti-PD-L1) - Primary antibody, specific to CD274, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Programmed cell death 1 ligand 1 inhibitor
Synonyms B7 H antibody | B7 H1 antibody | B7 homolog 1 antibody | B7-H1 antibody | B7H antibody | B7H1 antibody | CD 274 antibody | CD-274 antibody | CD274 antibody | CD274 antigen antibody | CD274 molecule antibody | MGC142294 antibody | MGC142296 antibody | OTTH
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity CD274
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Programmed cell death 1 ligand 1 inhibitor
Product Description

Socazolimab (anti-PD-L1) is an anti-PD-L1 monoclonal antibody. Socazolimab (anti-PD-L1) has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab (anti-PD-L1) also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma.

Purity

>95% (SDS-PAGE&SEC)

Endotoxin Level

< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type lambda
SDS-PAGE 28.0 kDa (Light Chain) & 52.0 kDa (Heavy Chain), under reducing conditions; 207.2 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95% (SDS-PAGE&SEC)
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2305043-30-3

Associated Targets(Human)

CD274 Tclin Programmed cell death 1 ligand 1 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Socazolimab (anti-PD-L1) (Ab182948) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling PD-L1 (red) with Socazolimab (anti-PD-L1) (Ab182948). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Socazolimab (anti-PD-L1) (Ab182948) - ELISA
Immobilized Recombinant Human PD-L1 protein (rp169666) at 1.0 μg/mL can bind Socazolimab (anti-PD-L1) (Ab182948) with the EC50 of 97.84 ng/mL.

Socazolimab (anti-PD-L1) (Ab182948) - SEC
The purity of Socazolimab (anti-PD-L1) (Ab182948) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0606992 Certificate of Analysis Jun 19, 2024 Ab182948
ZJ24F0606991 Certificate of Analysis Jun 19, 2024 Ab182948
ZJ24F0606990 Certificate of Analysis Jun 19, 2024 Ab182948

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.